Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Thomas S, Prendergast GC
In the first head-to-head trial, SURMOUNT-5 (2025), tirzepatide beat semaglutide directly 20.2% versus 13.7% over 72 weeks (New England Journal of Medicine, 2025)
Therapy Overview Consent documents should explain what GLP-1 receptor agonists are and how they may support weight management
Obesity is defined as a body mass index (BMI) of 30 or higher
That amount may cause side effects and is not appropriate for everyone
However, there are effective strategies to manage and potentially mitigate this side effect
US$ 28.26
US$ 21.74
US$ 21.92
US$ 29.84
US$ 28.53
US$ 29.69
US$ 23.80
US$ 24.50
US$ 27.55
